hs-CRP vs CRP: Inflammation Testing and Cardiovascular Risk
C-reactive protein, or CRP, is a protein made by your liver in response to inflammation. A standard CRP blood test and a high-sensitivity CRP test measure the same protein. The difference is how precisely they measure low concentrations—and the clinical questions they help answer.
An hs-CRP result can contribute to cardiovascular risk assessment, but it cannot show where inflammation is occurring, identify a blocked artery, or establish a diagnosis. Its usefulness depends on your health when the sample was collected and your broader risk profile.
This guide is informational and is not a substitute for professional medical advice. Discuss results with a licensed healthcare provider.
What is the difference between CRP and hs-CRP?
Short answer: Both tests measure C-reactive protein, but an hs-CRP test measures low concentrations more precisely. Standard CRP testing is generally used to assess more substantial inflammation, while hs-CRP can help refine cardiovascular risk assessment.
- Evidence: CRP rises with inflammation from many causes. High-sensitivity assays can measure the smaller differences relevant to cardiovascular risk assessment in otherwise stable adults.
- Exceptions: Neither test identifies the cause or location of inflammation. During an acute illness, an hs-CRP result may mainly reflect that illness rather than your usual cardiovascular risk.
- Sample type: Blood, commonly venous blood processed into serum or plasma. At-home collection formats vary; confirm the sample requirements for the specific kit.
- Relevant test: The hs-CRP Test – High-Sensitivity CRP measures the marker discussed here.
- Medical source: NIH MedlinePlus, C-Reactive Protein (CRP) Test.
Think of the distinction as a difference in measurement sensitivity, not two different kinds of inflammation. A standard CRP test may be useful when a clinician is evaluating an infection, inflammatory condition, or changes in an established illness. The high-sensitivity method is designed to measure CRP reliably at much lower concentrations.
This distinction matters when reading a report. A standard CRP result reported as below the laboratory’s reporting limit may not provide enough detail to place you in an hs-CRP cardiovascular risk category. Check whether the test name specifically says “high-sensitivity CRP,” “hs-CRP,” or an equivalent designation.
“High-sensitivity” does not mean the test is specific to heart disease. A respiratory infection, injury, or inflammatory disorder can raise the same protein.
What is a normal hs-CRP level?
Short answer: For cardiovascular risk assessment in a clinically stable adult, an hs-CRP below 1 mg/L is traditionally considered a lower-risk result; 1–3 mg/L is an average-risk category, and above 3 mg/L is a higher-risk category. These are risk categories, not diagnostic cutoffs or a universal definition of normal.
- Evidence: The CDC/American Heart Association scientific statement established these categories. ACC/AHA guidance also identifies hs-CRP of at least 2 mg/L, if measured, as a risk-enhancing factor in selected cardiovascular risk discussions.
- Exceptions: Acute illness and other inflammatory conditions can make cardiovascular interpretation misleading. A result above 10 mg/L generally warrants assessment for another inflammatory cause and repeat measurement when stable.
- Sample type: Blood analyzed with a high-sensitivity CRP assay; results are usually reported in mg/L.
- Medical source: CDC/AHA, Markers of Inflammation and Cardiovascular Disease; ACC/AHA, 2019 Guideline on the Primary Prevention of Cardiovascular Disease.
The traditional categories describe relative risk across groups of people. They do not calculate your personal chance of a heart attack. Someone with hs-CRP below 1 mg/L may still have substantial risk because of smoking, high LDL cholesterol, diabetes, high blood pressure, or family history.
The 2 mg/L risk-enhancing threshold and the traditional 1–3 mg/L category serve different purposes. For example, 2.5 mg/L falls in the traditional average-risk category but also meets the ACC/AHA risk-enhancing threshold. A clinician uses this information alongside—not instead of—other risk factors.
Check the units before comparing results. One mg/dL equals 10 mg/L, so 0.2 mg/dL is the same concentration as 2 mg/L. Also distinguish the laboratory’s reference interval from thresholds used in cardiovascular guidelines.
A result above 10 mg/L is not proof of an infection or a cardiovascular emergency. It should not simply be labeled “very high heart risk,” either. If it remains elevated after repeat testing, a clinician can evaluate persistent inflammatory causes and its broader significance.
What can temporarily raise hs-CRP?
Short answer: Recent infection, injury, surgery, an inflammatory flare, or unusually strenuous exercise can temporarily raise hs-CRP. Testing while you are well and recovered from these events gives a more useful estimate of your baseline.
- Evidence: CRP is an acute-phase protein that increases in response to inflammatory signals. CDC/AHA guidance recommends cardiovascular testing in a metabolically stable person without an obvious infectious or inflammatory condition.
- Exceptions: An elevation is not always temporary. Smoking, higher body fat, and chronic inflammatory conditions can be associated with persistently higher levels.
- Sample type: Blood. The same biological influences affect CRP regardless of whether collection occurs at home or in a clinic.
- Medical source: NIH MedlinePlus, C-Reactive Protein (CRP) Test; CDC/AHA, Markers of Inflammation and Cardiovascular Disease.
Relevant temporary influences include:
- Infections: A respiratory, urinary, dental, or other infection can increase CRP, including during recovery.
- Tissue injury: Surgery, trauma, burns, and significant muscle injury can trigger an inflammatory response.
- Inflammatory flares: Increased activity of a condition such as rheumatoid arthritis can affect the result.
- Unusually intense exercise: A marathon or demanding workout that causes substantial muscle damage may temporarily increase CRP. Ordinary daily activity is not equivalent to this.
Pregnancy and estrogen-containing medications can also affect CRP interpretation, although these are not necessarily brief fluctuations. Tell the clinician reviewing your results about relevant health conditions, recent events, and all medications and supplements.
There is no single waiting period that fits every infection, operation, or exercise event. Recovery time and the reason for testing matter. A clinician can help decide when a result would best represent your baseline.
Who benefits from an hs-CRP test for cardiovascular risk?
Short answer: An hs-CRP test may be useful for selected adults when a clinician is uncertain about cardiovascular risk after reviewing standard risk factors. It is not a necessary screening test for everyone.
- Evidence: ACC/AHA guidance includes hs-CRP of at least 2 mg/L among risk-enhancing factors. The USPSTF has found insufficient evidence to determine the benefits and harms of routinely adding hs-CRP to traditional risk assessment in asymptomatic adults.
- Exceptions: People with known cardiovascular disease or clearly high risk may already have an established care plan that an hs-CRP result would not meaningfully change.
- Sample type: Blood for hs-CRP and lipid measurements; a broader assessment also requires information such as blood pressure, smoking history, and medical history.
- Relevant test: The Heart Health Test – Lipids & Inflammation is a related panel option; review its current marker list and collection requirements before ordering.
- Medical source: 2019 ACC/AHA Primary Prevention Guideline; USPSTF, Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors.
These recommendations address different questions. ACC/AHA guidance explains how a result can inform an individual clinical discussion. The USPSTF assessment considers whether adding the test to routine screening has been shown to improve health outcomes across asymptomatic populations. An association with risk does not automatically prove that universal testing is beneficial.
A useful starting question is: “Would this result change how my clinician understands my risk?” Blood pressure, cholesterol, diabetes status, smoking, age, and family history generally remain more foundational than an isolated inflammation measurement.
Hs-CRP does not measure arterial plaque or establish whether an artery is narrowed. It also cannot rule out heart disease when the result is low.
How should you prepare for an hs-CRP test, and when should it be repeated?
Short answer: An hs-CRP test alone usually does not require fasting, but a combined panel may have additional instructions. For cardiovascular assessment, testing when stable—and sometimes repeating the measurement—helps reduce the influence of temporary fluctuations.
- Evidence: The CDC/AHA statement describes using two measurements, optimally about two weeks apart, to improve baseline assessment. Results above 10 mg/L should prompt evaluation and repeat testing rather than immediate cardiovascular categorization.
- Exceptions: A clinician investigating active inflammation may intentionally test during illness. Repeat timing should reflect recovery and the clinical question, not a rigid calendar rule.
- Sample type: Blood. Follow the specific laboratory or kit instructions for collection, labeling, storage, and shipping.
- Medical source: CDC/AHA scientific statement on inflammatory markers; NIH MedlinePlus, CRP testing information.
Before collection, review whether you have recently had fever, infection, surgery, injury, or unusually demanding exercise. Record anything relevant so the result can be interpreted in context. Follow the ordering clinician’s instructions about scheduling and preparation.
If hs-CRP is bundled with other tests, follow the instructions for the full panel rather than assuming that all components have the same requirements. Ask the laboratory or clinician if the instructions are unclear.
For comparisons over time, using the same laboratory and method can reduce one source of variation. A small numerical change does not necessarily indicate a meaningful change in health, especially when your health status or collection conditions differed.
How reliable is an at-home hs-CRP test?
Short answer: Reliability depends on the assay, its validation for the collected sample, and correct collection and handling. “At home” describes where collection or testing occurs; it does not by itself establish accuracy.
- Evidence: FDA guidance emphasizes following home-test instructions and interpreting results with healthcare professionals. Laboratory certification and accreditation concern laboratory quality systems, not certainty about an individual result.
- Exceptions: An insufficient sample, improper storage, shipping problems, or an unsuitable collection method can affect testing. Do not assume that every finger-prick or dried blood spot method is interchangeable with venous testing.
- Sample type: Conventional testing commonly uses venous serum or plasma. At-home kits may use capillary blood; verify the exact format and requirements for the selected product.
- Relevant test: Samples for the hs-CRP Test – High-Sensitivity CRP are analyzed in a CLIA-certified, CAP-accredited laboratory.
- Medical source: FDA, Home Use Tests; CMS, Clinical Laboratory Improvement Amendments.
Before ordering, confirm that the product specifically measures high-sensitivity CRP, how the sample is collected, and whether the service is available in your state. Direct-to-consumer laboratory testing is restricted in some states, and availability should not be assumed nationwide.
There are two separate issues: whether the laboratory measured CRP appropriately and whether that result represents your usual health. Even a technically sound measurement can be a poor estimate of baseline cardiovascular risk if collected during an infection.
An at-home test provides information; it does not diagnose a condition. Unexpected results may require repeat testing or additional clinical assessment.
What should you do with an elevated hs-CRP result?
Short answer: Review the result with a licensed healthcare provider, including your recent health history and established cardiovascular risk factors. The next step is usually clarification of context—not assuming a particular disease or trying to interpret the number alone.
- Evidence: Cardiovascular guidelines use hs-CRP as supporting information within an overall risk assessment. CRP is nonspecific, so an elevated result cannot establish its cause.
- Exceptions: Symptoms require assessment on their own merits. A normal hs-CRP result does not rule out an urgent heart problem or another serious condition.
- Sample type: Repeat blood testing may be appropriate; any additional testing depends on the clinical assessment.
- Medical source: 2019 ACC/AHA Primary Prevention Guideline; NIH MedlinePlus, CRP testing information.
Bring the complete report, including units, the laboratory’s reference information, collection date, and whether the assay was high-sensitivity. Note recent illness, exercise, injury, or other possible influences.
Useful questions include whether the result needs repeating, whether it changes your overall risk assessment, and whether symptoms or persistent elevation warrant further evaluation. A persistently elevated result can matter, but it still does not reveal the source of inflammation.
If you develop chest pain, severe shortness of breath, or other possible emergency symptoms, seek emergency care rather than waiting for an inflammation test. Hs-CRP is not an emergency triage test.
Bottom line: CRP and hs-CRP measure the same protein for different clinical purposes. Hs-CRP is most informative when measured during stable health and interpreted alongside the factors that already shape cardiovascular risk.
What does high hs-CRP tell you about heart health, and how does inflammation affect heart disease risk?
Short answer: High hs-CRP can be a signal of inflammatory activity associated with cardiovascular risk. Inflammation contributes to atherosclerosis—the buildup of plaque in arteries—but an elevated hs-CRP does not prove that inflammation is occurring in your heart.
- Evidence: Inflammatory cells participate in plaque development and can make plaque more likely to rupture. However, genetic research does not support assuming that CRP itself causes coronary heart disease.
- Exceptions: A risk marker is not necessarily a cause of disease. A lower hs-CRP number alone does not establish that arterial plaque has decreased or that cardiovascular risk has improved.
- Sample type: Blood analyzed using a high-sensitivity CRP assay.
- Relevant test: The hs-CRP Test – High-Sensitivity CRP measures this circulating inflammation marker, not plaque inflammation directly.
- Medical source: NHLBI, Atherosclerosis; BMJ, Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis.
Inflammation and cholesterol interact within artery walls. Immune cells respond to retained cholesterol-containing particles, take up lipids, and help sustain inflammation within developing plaque. In some plaques, inflammatory activity can weaken the protective fibrous covering. If a plaque ruptures, a blood clot can form and obstruct blood flow, potentially causing a heart attack.
This helps explain why inflammation matters beyond the amount of cholesterol in the bloodstream. It also explains an important distinction: hs-CRP is a measurable signal associated with this biology, not a direct measurement of what is happening inside an individual plaque. Demonstrating that a marker predicts risk is different from demonstrating that changing that marker itself improves health outcomes.
What blood test measures inflammation in the heart?
Short answer: No single routine blood test specifically measures inflammation inside the heart. CRP checks general inflammatory activity, while cardiac troponin checks for heart muscle injury. Clinicians may use both when evaluating suspected heart inflammation, alongside other assessments.
- Evidence: Evaluation of heart inflammation may include blood tests, an electrocardiogram, and imaging such as echocardiography or cardiac MRI. Troponin can rise when heart muscle cells are injured, including in myocarditis.
- Exceptions: Elevated troponin has several possible causes and does not by itself establish myocarditis. Inflammation of the heart muscle and inflammation of the sac surrounding the heart are different conditions and may require different evaluations.
- Sample type: Blood, usually collected from a vein in a clinical setting; imaging and electrical tests do not require a blood sample.
- Relevant test: None of the listed products specifically measures inflammation within the heart muscle or replaces an evaluation for suspected heart inflammation.
- Medical source: NHLBI, Heart Inflammation; NIH MedlinePlus, Troponin Test.
The phrase “heart inflammation” can refer to myocarditis, which affects heart muscle, or pericarditis, which affects the sac around the heart. These are distinct from the inflammatory processes involved in arterial plaque. Testing intended to refine long-term cardiovascular risk is therefore not interchangeable with evaluating suspected myocarditis or pericarditis.
Also, “high-sensitivity troponin” and “high-sensitivity CRP” are different tests. High-sensitivity describes the ability to measure low concentrations; it does not mean the tests measure the same process. Troponin provides information about heart muscle injury, whereas CRP provides information about inflammatory activity.
This information is educational and is not a substitute for professional medical advice. Discuss results and any symptoms with a licensed healthcare provider.




